Jump to content

Search the hub

Showing results for tags 'Medicine - Rheumatology'.

More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Learning news archive
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous
    • Health care
    • Social care
    • Jobs and voluntary positions
    • Suggested resources

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End

Group

First name

Last name

Country

Join a private group (if appropriate)

About me

Organisation

Role

Found 18 results
  1. Content Article
  2. Content Article
    Making a decision about Dupuytren’s contracture Making a decision about carpal tunnel syndrome Making a decision about hip osteoarthritis Making a decision about knee osteoarthritis Making a decision about further treatment for atrial fibrillation Making a decision about cataracts Making a decision about glaucoma Making a decision about wet age-related macular degeneration
  3. Content Article
  4. Content Article
    In this paper, ARMA makes the following recommendations: Develop multidisciplinary, networked, personalised approaches to pain as standard. Develop more community-based approaches to pain. Everyone with chronic pain should be offered a holistic assessment of their symptoms in primary care reviewing the impact on their physical and mental health, their activities of daily living and their wellbeing, including the ability to work/study, and explore any underlying causes of or contributors to their pain. A public health approach is needed based on community need to design and
  5. Content Article
  6. Content Article
  7. Content Article
    Current modules available: Foundation Newly diagnosed Meet the team Managing pain and flares A module on Medicines and Treatment (to be launched)
  8. Content Article
  9. Content Article
    A few weeks ago, a painful and rapidly-swelling elbow forced me to pick up the phone and ask for help. I have rheumatoid arthritis, treated by immunosuppressive biologic drugs and complicated by other health issues. In ‘normal times' I am supposed to see my consultant every six months. But due to Covid-19, I had not seen her in two years and was muddling along by myself. So I wrote myself a script, made sure I had all the information I needed and psyched myself up to fight for an appointment with whoever I reached after navigating the hospital switchboard. Amazingly, I got through to my r
  10. News Article
    A drug used to treat rheumatoid arthritis appears to help patients who are admitted to intensive care with the most severe coronavirus infections, researchers say. Tocilizumab, a medicine that dampens down inflammation, improved outcomes for critically ill patients, according to early results from an international trial investigating whether the drug and others like it boost survival rates and reduce the amount of time patients spend in intensive care. The findings have not been peer-reviewed or published in a journal, but if confirmed by more trial data, the drug will be on track to
  11. Content Article
    The rheumatology community has created a global, coordinated and timely response to the COVID-19 pandemic. The alliance aims to harness the breadth of expertise and knowledge in the rheumatology physician and patient communities to advance knowledge about COVID-19 for the benefit of all patients with rheumatic diseases.
  12. Content Article
  13. Content Article
    The report addresses MSK inequalities in the following categories: Digital access and health literacy Communities Prevention Children and young people Data Waiting lists Care gap Status of MSK
  14. Content Article
  15. Content Article
  16. Content Article
    This GIRFT report for rheumatology makes 23 recommendations to improve care for patients including: redesigning services for patients with non-inflammatory painful musculoskeletal conditions. reducing hospital visits. improving access to care for rare conditions. You will need a FutureNHS account to view this report, or you can watch: a short video summary of the report which includes key recommendations. the recording of a webinar about the report held on 1 October 2021.
  17. Content Article
    The authors of the study conducted surveys and interviews with patients and clinicians between April and July 2021. The majority of patients were from the UK and had inflammatory arthritis or lupus. The study found the following: Patients and clinicians rated telemedicine as worse than face-to-face consultations in almost all categories, although >60% found it more convenient. 93% of clinicians and 86% of patients rated telemedicine as worse than face-to-face for assessment accuracy. Building trusting medical relationships was a great concern. Telemedicine was perc
  18. Content Article
    Key findings of the report include: 47% of Black, Asian and ethnic minority patients and 43% of white patients were referred to rheumatology services within three working days of presenting (Quality statement 1) 43% of Black, Asian and ethnic minority patients and 42% of white patients were assessed within three weeks of referral 2013 version of QS33 (Quality statement 2) A higher proportion of Black, Asian and ethnic minority patients (60%) received timely treatment compared to white patients (57%) (Quality statement 2) A high proportion of both groups of patients we
×